These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1775593)

  • 21. The safety of psychotropic drug use during pregnancy: a review.
    Einarson A
    MedGenMed; 2005 Oct; 7(4):3. PubMed ID: 16614625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning.
    Gainotti G; Benedetti N; Caltagirone C; Nocentini U
    Clin Neuropharmacol; 1986; 9 Suppl 3():S65-9. PubMed ID: 3297320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Problems of drug treatment of mental disorders.
    Vartanian FE
    Adv Biochem Psychopharmacol; 1980; 24():603-7. PubMed ID: 6996446
    [No Abstract]   [Full Text] [Related]  

  • 24. Selection and utilization of outcome measures in psychiatric clinical trials. Report on the 1988 MacArthur Foundation Network I Methodology Institute.
    Kraemer HC; Telch CF
    Neuropsychopharmacology; 1992 Sep; 7(2):85-94. PubMed ID: 1418305
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucocorticoid antagonists in neuropsychiatric [corrected] disorders.
    Schatzberg AF; Lindley S
    Eur J Pharmacol; 2008 Apr; 583(2-3):358-64. PubMed ID: 18339372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotropic blood levels: a guide to clinical response.
    Yesavage JA
    J Clin Psychiatry; 1986 Sep; 47 Suppl():16-9. PubMed ID: 2875066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).
    Pharmacopsychiatria; 1981 Sep; 14(5):190-9. PubMed ID: 7291302
    [No Abstract]   [Full Text] [Related]  

  • 28. [Planning of psychotropic drug trials. Control of interfering factors].
    Schmocker AM
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):149-51. PubMed ID: 360239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview.
    Ereshefsky L; Jann MW; Saklad SR; Davis CM
    J Clin Psychiatry; 1986 Sep; 47 Suppl():6-15. PubMed ID: 3528134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotropic drug epidemiology: the road travelled, the road ahead.
    Barbui C; Tansella M
    Int Rev Psychiatry; 2005 Jun; 17(3):143-51. PubMed ID: 16194785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of clinical psychiatry in the development of new drugs].
    Benkert O; Hippius H
    Arzneimittelforschung; 1975 Jul; 25(7a):1195-206. PubMed ID: 1242348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New psychotherapeutic drugs.
    Hollister LE
    J Clin Psychopharmacol; 1994 Feb; 14(1):50-63. PubMed ID: 8151004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New psychotropic drug developments in the USSR and other Eastern European countries.
    Herrmann WM
    Psychopharmacol Bull; 1975 Apr; 11(2):24-8. PubMed ID: 1094485
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors contributing to failed trials of new agents: can technology prevent some problems?
    Greist JH; Mundt JC; Kobak K
    J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.
    Matson JL; Neal D
    Res Dev Disabil; 2009; 30(3):572-86. PubMed ID: 18845418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multicenter psychopharmacologic research and the data bank].
    Cassano GB; Conti L; Massimetti G
    Acta Psychiatr Belg; 1983; 83(3):267-81. PubMed ID: 6356790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Issues in clinical trials of prophylaxis of fungal infections.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S211-7. PubMed ID: 15546120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Statistical aspects in planning psychotropic drug trials (author's transl)].
    Ferner U
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):132-9. PubMed ID: 360237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.